Eli M. Carrami

SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers

R. Bast, G. Calin, Y. Xi, 2022, The Journal of clinical investigation.

An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment

Zhiyuan Hu, H. Saya, A. Ahmed, 2018, Oncogene.

Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation

R. Bast, S. Knapp, N. Gray, 2018, Nature Communications.

Perspective on the combined use of an independent transgenic sexing and a multifactorial reproductive sterility system to avoid resistance development against transgenic Sterile Insect Technique approaches

Stefan Dippel, E. Wimmer, I. Curril, 2014, BMC Genetics.

Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

J. Danesh, M. Daly, J. Stelling, 2020, Nature Communications.

Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation

C. Yau, R. Bast, S. Knapp, 2018, Nature Communications.